Abeona Therapeutics
ABEO
45 hedge funds and large institutions have $19.5M invested in Abeona Therapeutics in 2016 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 4 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
0% more funds holding
Funds holding: 45 → 45 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
25% less capital invested
Capital invested by funds: $26M → $19.5M (-$6.43M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$203K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
+$90.3K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$71.7K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$62.8K |
| 5 |
SG Americas Securities
New York
|
+$43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GP
GLG Partners
London,
United Kingdom
|
-$434K |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$350K |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$72K |
| 4 |
D.E. Shaw & Co
New York
|
-$44K |
| 5 |
IA
IFP Advisors
Tampa,
Florida
|
-$39.7K |
ABEO Hedge Fund Activity: Q1 2016 in Review
45 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics (ABEO) for Q1 2016, worth a combined $19.5M — down 25% from $26M a quarter earlier.
Fund positioning in ABEO was balanced in Q1 2016: 4 funds opened new positions, 4 closed out, 14 added to existing stakes and 9 trimmed.
The largest buyer was Royce & Associates, adding an estimated $203K. The largest seller was GLG Partners, exiting entirely with an estimated $434K sold.
- 45 institutional investors held Abeona Therapeutics (ABEO) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $19.5M of Abeona Therapeutics stock for Q1 2016, down 25% quarter-over-quarter.
- 4 funds opened new Abeona Therapeutics positions in Q1 2016 and 4 closed out, a net change of 0 holders.
- The largest Abeona Therapeutics buyer in Q1 2016 was Royce & Associates, an estimated $203K added.
- The largest Abeona Therapeutics seller in Q1 2016 was GLG Partners, an estimated $434K sold.
Based on aggregated 13F filings for Q1 2016.